Viagra vs. Cialis: Little Blue Pill Is Losing Big

Dec. 19 (Bloomberg) -- Bloomberg's Eric Chemi take a look at the two most popular erectile dysfunction medications on the market, Viagra and Cialis. Pfizer, the maker of Viagra, eliminated 20% of its sales workforce on December 18.
Management Can Take Credit for Santander Earnings: Costa
11:34 - Robert Kennedy College Zurich Dean David Costa discusses Santander earnings and his thoughts on banking for the whole of the EU. He speaks with Francine Lacqua and Guy Johnson on Bloomberg Television’s “The Pulse.” (Source: Bloomberg)
  • Politicians Spin U.K. GDP Number
  • Never Buy Stock for Takeover Prospect: Chillingworth
  • BP 1Q Adj. Profit Beats Analysts’ Estimates